Cargando…
Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatiti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982956/ https://www.ncbi.nlm.nih.gov/pubmed/20842394 http://dx.doi.org/10.1007/s00705-010-0789-7 |
_version_ | 1782191775268470784 |
---|---|
author | Figlerowicz, Magdalena Jackowiak, Paulina Formanowicz, Piotr Kędziora, Paweł Alejska, Magdalena Malinowska, Nelli Błażewicz, Jacek Figlerowicz, Marek |
author_facet | Figlerowicz, Magdalena Jackowiak, Paulina Formanowicz, Piotr Kędziora, Paweł Alejska, Magdalena Malinowska, Nelli Błażewicz, Jacek Figlerowicz, Marek |
author_sort | Figlerowicz, Magdalena |
collection | PubMed |
description | Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatitis C (CHC) subjected to interferon–ribavirin therapy. The structures of the viral quasispecies were established based on a 132-amino-acid sequence derived from E1/E2 protein, including hypervariable region 1 (HVR1). Two types of HCV populations were identified. The first type, found in non-responders, contained a small number of closely related variants. The second type, characteristic for sustained responders, was composed of a large number of distantly associated equal-rank variants. Comparison of 445 HVR1 sequences showed that a significant number of variants present in non-responding patients are closely related, suggesting that certain, still unidentified properties of the pathogen may be key factors determining the result of CHC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00705-010-0789-7) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-2982956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-29829562010-12-15 Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy Figlerowicz, Magdalena Jackowiak, Paulina Formanowicz, Piotr Kędziora, Paweł Alejska, Magdalena Malinowska, Nelli Błażewicz, Jacek Figlerowicz, Marek Arch Virol Original Article Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatitis C (CHC) subjected to interferon–ribavirin therapy. The structures of the viral quasispecies were established based on a 132-amino-acid sequence derived from E1/E2 protein, including hypervariable region 1 (HVR1). Two types of HCV populations were identified. The first type, found in non-responders, contained a small number of closely related variants. The second type, characteristic for sustained responders, was composed of a large number of distantly associated equal-rank variants. Comparison of 445 HVR1 sequences showed that a significant number of variants present in non-responding patients are closely related, suggesting that certain, still unidentified properties of the pathogen may be key factors determining the result of CHC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00705-010-0789-7) contains supplementary material, which is available to authorized users. Springer Vienna 2010-09-15 2010 /pmc/articles/PMC2982956/ /pubmed/20842394 http://dx.doi.org/10.1007/s00705-010-0789-7 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Figlerowicz, Magdalena Jackowiak, Paulina Formanowicz, Piotr Kędziora, Paweł Alejska, Magdalena Malinowska, Nelli Błażewicz, Jacek Figlerowicz, Marek Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title | Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title_full | Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title_fullStr | Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title_full_unstemmed | Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title_short | Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
title_sort | hepatitis c virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982956/ https://www.ncbi.nlm.nih.gov/pubmed/20842394 http://dx.doi.org/10.1007/s00705-010-0789-7 |
work_keys_str_mv | AT figlerowiczmagdalena hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT jackowiakpaulina hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT formanowiczpiotr hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT kedziorapaweł hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT alejskamagdalena hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT malinowskanelli hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT błazewiczjacek hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy AT figlerowiczmarek hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy |